Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

2.480%
0.15
2.480%
€11.36
 
07:32 / Stuttgart Stock Exchange WKN: A1XB32 / Symbol: INGN / Name: Inogen / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Inogen Inc. Stock

There is an upward development for Inogen Inc. compared to yesterday, with an increase of €0.15 (2.480%).
Currently there is a rather positive sentiment for Inogen Inc. with 3 Buy predictions and 1 Sell predictions.
With a target price of 11 € there is a hugely positive potential of 77.42% for Inogen Inc. compared to the current price of 6.2 €.

Pros and Cons of Inogen Inc. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Inogen Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Inogen Inc. 2.480% -0.833% 8.182% -17.361% -26.543% -73.904% -81.289%
SI-BONE Inc -0.640% 0.654% -6.098% 29.412% 18.462% - -
Orasure Tech 0.790% -1.563% 0.800% -36.041% -26.316% -1.563% -74.673%
scPharmaceuticals 3.030% -4.406% 3.327% -20.402% -2.222% -32.596% -49.312%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-10-30

Upon examining the financial data supplied for Inogen Inc. — a prominent player in the Healthcare Equipment and Supplies industry — it's clear to see that the company has recently navigated a challenging financial landscape. Notably, over the past three operational years, a trend of fluctuating balance sheets, income statements, and cash flow data seems to suggest volatility in the company's financial standing.

A deeper look into Inogen's financials reveals some potential strengths. Despite fluctuating numbers, the company demonstrated a notable increase in total assets from 2020 to 2021, highlighting an opportunistic approach to resource acquisition. Additionally, Inogen's total revenue seemingly reflected a steady upward trend from 2020 to 2022, indicating an increase in incoming cash - a crucial factor for any growing firm.

In terms of financial ratios for valuation, the Price to Sales (P/S) ratio (PriceSalesTTM) for the trailing 12 months (TTM) is currently at 1.2258. This suggests that investors are willing to pay over a dollar for each dollar of sales, reflecting perceived value in the company's income-generating abilities. Moreover, the company's enticing Book Value of 11.847 implies significant intrinsic value, which may encourage investor confidence.

Comments

Inogen, Inc. (NASDAQ: INGN) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Ratings data for INGN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 9.57%
Target price 12.141
Change
Ends at 16.06.26

Inogen, Inc. (NASDAQ: INGN) is now covered by analysts at B. Riley. They set a "buy" rating and a $14.00 price target on the stock.
Ratings data for INGN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.13%
Target price 10.583
Change
Ends at 22.05.26

Inogen, Inc. (NASDAQ: INGN) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock.
Ratings data for INGN provided by MarketBeat
Show more

News

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy
Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy


Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of VoxiTM 5, a new stationary oxygen

Inogen Announces First Quarter 2025 Financial Results
Inogen Announces First Quarter 2025 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31

Inogen to Report First Quarter 2025 Financial Results on May 7, 2025
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2025 financial